nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—TYMP—pancreatic cancer	0.542	1	CbGaD
Cidofovir—TYMP—Fluorouracil—pancreatic cancer	0.32	1	CbGbCtD
Cidofovir—TYMP—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00406	0.182	CbGpPWpGaD
Cidofovir—TYMP—Pyrimidine catabolism—DPYD—pancreatic cancer	0.00363	0.163	CbGpPWpGaD
Cidofovir—TYMP—Pyrimidine metabolism—DPYD—pancreatic cancer	0.00208	0.0934	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.00161	0.0724	CbGpPWpGaD
Cidofovir—TYMP—Pyrimidine metabolism—TYMS—pancreatic cancer	0.00119	0.0532	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00092	0.0413	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—DPYD—pancreatic cancer	0.000812	0.0364	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—EGF—pancreatic cancer	0.000702	0.0315	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—RB1—pancreatic cancer	0.000656	0.0294	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDH1—pancreatic cancer	0.000653	0.0293	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CDKN2A—pancreatic cancer	0.000577	0.0258	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CXCL8—pancreatic cancer	0.000523	0.0234	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—CCND1—pancreatic cancer	0.000487	0.0218	CbGpPWpGaD
Cidofovir—TYMP—Nucleotide metabolism—TYMS—pancreatic cancer	0.000462	0.0207	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—VEGFA—pancreatic cancer	0.000425	0.019	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—MYC—pancreatic cancer	0.000391	0.0175	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—EGFR—pancreatic cancer	0.000382	0.0171	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—TP53—pancreatic cancer	0.000321	0.0144	CbGpPWpGaD
Cidofovir—TYMP—Bladder Cancer—HRAS—pancreatic cancer	0.000307	0.0138	CbGpPWpGaD
Cidofovir—TYMP—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000305	0.0137	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00027	0.0121	CbGpPWpGaD
Cidofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.000224	0.0101	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000168	0.00754	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000137	0.00614	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PRSS1—pancreatic cancer	0.000123	0.0055	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—ARG2—pancreatic cancer	0.000106	0.00477	CbGpPWpGaD
Cidofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000102	0.00457	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GLP1R—pancreatic cancer	7.49e-05	0.00336	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—DPYD—pancreatic cancer	7.37e-05	0.00331	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—SLC2A2—pancreatic cancer	7e-05	0.00314	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—CD44—pancreatic cancer	5.42e-05	0.00243	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—GCG—pancreatic cancer	5.19e-05	0.00233	CbGpPWpGaD
Cidofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.18e-05	0.00232	CbGpPWpGaD
Cidofovir—Bronchitis—Doxorubicin—pancreatic cancer	5.08e-05	0.000441	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	5.04e-05	0.000438	CcSEcCtD
Cidofovir—Arthralgia—Docetaxel—pancreatic cancer	5.02e-05	0.000436	CcSEcCtD
Cidofovir—Chest pain—Docetaxel—pancreatic cancer	5.02e-05	0.000436	CcSEcCtD
Cidofovir—Myalgia—Docetaxel—pancreatic cancer	5.02e-05	0.000436	CcSEcCtD
Cidofovir—Nausea—Sunitinib—pancreatic cancer	5.02e-05	0.000436	CcSEcCtD
Cidofovir—Pancytopenia—Doxorubicin—pancreatic cancer	5.01e-05	0.000436	CcSEcCtD
Cidofovir—Renal failure—Epirubicin—pancreatic cancer	5e-05	0.000435	CcSEcCtD
Cidofovir—Asthenia—Irinotecan—pancreatic cancer	4.99e-05	0.000434	CcSEcCtD
Cidofovir—Neuropathy peripheral—Epirubicin—pancreatic cancer	4.99e-05	0.000433	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	4.98e-05	0.000433	CcSEcCtD
Cidofovir—Jaundice—Epirubicin—pancreatic cancer	4.96e-05	0.000431	CcSEcCtD
Cidofovir—Stomatitis—Epirubicin—pancreatic cancer	4.96e-05	0.000431	CcSEcCtD
Cidofovir—Urinary tract infection—Epirubicin—pancreatic cancer	4.94e-05	0.00043	CcSEcCtD
Cidofovir—Conjunctivitis—Epirubicin—pancreatic cancer	4.94e-05	0.00043	CcSEcCtD
Cidofovir—Dysuria—Doxorubicin—pancreatic cancer	4.94e-05	0.000429	CcSEcCtD
Cidofovir—Neutropenia—Doxorubicin—pancreatic cancer	4.94e-05	0.000429	CcSEcCtD
Cidofovir—Hypersensitivity—Fluorouracil—pancreatic cancer	4.91e-05	0.000427	CcSEcCtD
Cidofovir—Dry mouth—Docetaxel—pancreatic cancer	4.91e-05	0.000427	CcSEcCtD
Cidofovir—TYMP—Metabolism—STK11—pancreatic cancer	4.88e-05	0.00219	CbGpPWpGaD
Cidofovir—Sweating—Epirubicin—pancreatic cancer	4.88e-05	0.000424	CcSEcCtD
Cidofovir—Pollakiuria—Doxorubicin—pancreatic cancer	4.88e-05	0.000424	CcSEcCtD
Cidofovir—Asthenia—Gemcitabine—pancreatic cancer	4.86e-05	0.000423	CcSEcCtD
Cidofovir—Haematuria—Epirubicin—pancreatic cancer	4.85e-05	0.000422	CcSEcCtD
Cidofovir—Confusional state—Docetaxel—pancreatic cancer	4.85e-05	0.000422	CcSEcCtD
Cidofovir—Photosensitivity reaction—Doxorubicin—pancreatic cancer	4.82e-05	0.000419	CcSEcCtD
Cidofovir—Oedema—Docetaxel—pancreatic cancer	4.81e-05	0.000418	CcSEcCtD
Cidofovir—Anaphylactic shock—Docetaxel—pancreatic cancer	4.81e-05	0.000418	CcSEcCtD
Cidofovir—Weight increased—Doxorubicin—pancreatic cancer	4.8e-05	0.000418	CcSEcCtD
Cidofovir—Epistaxis—Epirubicin—pancreatic cancer	4.8e-05	0.000417	CcSEcCtD
Cidofovir—Pruritus—Gemcitabine—pancreatic cancer	4.8e-05	0.000417	CcSEcCtD
Cidofovir—Infection—Docetaxel—pancreatic cancer	4.78e-05	0.000415	CcSEcCtD
Cidofovir—Weight decreased—Doxorubicin—pancreatic cancer	4.78e-05	0.000415	CcSEcCtD
Cidofovir—Sinusitis—Epirubicin—pancreatic cancer	4.77e-05	0.000415	CcSEcCtD
Cidofovir—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.76e-05	0.000414	CcSEcCtD
Cidofovir—Diarrhoea—Irinotecan—pancreatic cancer	4.76e-05	0.000414	CcSEcCtD
Cidofovir—Pneumonia—Doxorubicin—pancreatic cancer	4.73e-05	0.000412	CcSEcCtD
Cidofovir—Shock—Docetaxel—pancreatic cancer	4.73e-05	0.000411	CcSEcCtD
Cidofovir—Nervous system disorder—Docetaxel—pancreatic cancer	4.72e-05	0.00041	CcSEcCtD
Cidofovir—Pruritus—Fluorouracil—pancreatic cancer	4.72e-05	0.00041	CcSEcCtD
Cidofovir—Thrombocytopenia—Docetaxel—pancreatic cancer	4.71e-05	0.000409	CcSEcCtD
Cidofovir—Tachycardia—Docetaxel—pancreatic cancer	4.69e-05	0.000408	CcSEcCtD
Cidofovir—Skin disorder—Docetaxel—pancreatic cancer	4.67e-05	0.000406	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	4.67e-05	0.000406	CcSEcCtD
Cidofovir—Diarrhoea—Gemcitabine—pancreatic cancer	4.64e-05	0.000403	CcSEcCtD
Cidofovir—Renal failure—Doxorubicin—pancreatic cancer	4.63e-05	0.000402	CcSEcCtD
Cidofovir—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.61e-05	0.000401	CcSEcCtD
Cidofovir—Dizziness—Irinotecan—pancreatic cancer	4.6e-05	0.0004	CcSEcCtD
Cidofovir—Jaundice—Doxorubicin—pancreatic cancer	4.59e-05	0.000399	CcSEcCtD
Cidofovir—Stomatitis—Doxorubicin—pancreatic cancer	4.59e-05	0.000399	CcSEcCtD
Cidofovir—Anorexia—Docetaxel—pancreatic cancer	4.59e-05	0.000399	CcSEcCtD
Cidofovir—Rhinitis—Epirubicin—pancreatic cancer	4.58e-05	0.000398	CcSEcCtD
Cidofovir—Urinary tract infection—Doxorubicin—pancreatic cancer	4.58e-05	0.000398	CcSEcCtD
Cidofovir—Conjunctivitis—Doxorubicin—pancreatic cancer	4.58e-05	0.000398	CcSEcCtD
Cidofovir—Hepatitis—Epirubicin—pancreatic cancer	4.57e-05	0.000397	CcSEcCtD
Cidofovir—Diarrhoea—Fluorouracil—pancreatic cancer	4.56e-05	0.000396	CcSEcCtD
Cidofovir—Pharyngitis—Epirubicin—pancreatic cancer	4.53e-05	0.000394	CcSEcCtD
Cidofovir—Sweating—Doxorubicin—pancreatic cancer	4.51e-05	0.000392	CcSEcCtD
Cidofovir—Urinary tract disorder—Epirubicin—pancreatic cancer	4.51e-05	0.000392	CcSEcCtD
Cidofovir—Oedema peripheral—Epirubicin—pancreatic cancer	4.5e-05	0.000391	CcSEcCtD
Cidofovir—Hypotension—Docetaxel—pancreatic cancer	4.49e-05	0.000391	CcSEcCtD
Cidofovir—Haematuria—Doxorubicin—pancreatic cancer	4.49e-05	0.00039	CcSEcCtD
Cidofovir—Urethral disorder—Epirubicin—pancreatic cancer	4.48e-05	0.000389	CcSEcCtD
Cidofovir—Epistaxis—Doxorubicin—pancreatic cancer	4.44e-05	0.000386	CcSEcCtD
Cidofovir—Vomiting—Irinotecan—pancreatic cancer	4.42e-05	0.000385	CcSEcCtD
Cidofovir—Sinusitis—Doxorubicin—pancreatic cancer	4.42e-05	0.000384	CcSEcCtD
Cidofovir—Dizziness—Fluorouracil—pancreatic cancer	4.41e-05	0.000383	CcSEcCtD
Cidofovir—Visual impairment—Epirubicin—pancreatic cancer	4.4e-05	0.000383	CcSEcCtD
Cidofovir—Rash—Irinotecan—pancreatic cancer	4.39e-05	0.000381	CcSEcCtD
Cidofovir—Dermatitis—Irinotecan—pancreatic cancer	4.38e-05	0.000381	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	4.38e-05	0.000381	CcSEcCtD
Cidofovir—Headache—Irinotecan—pancreatic cancer	4.36e-05	0.000379	CcSEcCtD
Cidofovir—Insomnia—Docetaxel—pancreatic cancer	4.35e-05	0.000378	CcSEcCtD
Cidofovir—Paraesthesia—Docetaxel—pancreatic cancer	4.32e-05	0.000375	CcSEcCtD
Cidofovir—Erythema multiforme—Epirubicin—pancreatic cancer	4.32e-05	0.000375	CcSEcCtD
Cidofovir—Vomiting—Gemcitabine—pancreatic cancer	4.31e-05	0.000375	CcSEcCtD
Cidofovir—Dyspnoea—Docetaxel—pancreatic cancer	4.29e-05	0.000373	CcSEcCtD
Cidofovir—Somnolence—Docetaxel—pancreatic cancer	4.28e-05	0.000372	CcSEcCtD
Cidofovir—Rash—Gemcitabine—pancreatic cancer	4.27e-05	0.000372	CcSEcCtD
Cidofovir—Dermatitis—Gemcitabine—pancreatic cancer	4.27e-05	0.000371	CcSEcCtD
Cidofovir—Eye disorder—Epirubicin—pancreatic cancer	4.27e-05	0.000371	CcSEcCtD
Cidofovir—Tinnitus—Epirubicin—pancreatic cancer	4.26e-05	0.00037	CcSEcCtD
Cidofovir—Headache—Gemcitabine—pancreatic cancer	4.25e-05	0.000369	CcSEcCtD
Cidofovir—Flushing—Epirubicin—pancreatic cancer	4.24e-05	0.000368	CcSEcCtD
Cidofovir—Vomiting—Fluorouracil—pancreatic cancer	4.24e-05	0.000368	CcSEcCtD
Cidofovir—Rhinitis—Doxorubicin—pancreatic cancer	4.24e-05	0.000368	CcSEcCtD
Cidofovir—Dyspepsia—Docetaxel—pancreatic cancer	4.23e-05	0.000368	CcSEcCtD
Cidofovir—Hepatitis—Doxorubicin—pancreatic cancer	4.23e-05	0.000367	CcSEcCtD
Cidofovir—Rash—Fluorouracil—pancreatic cancer	4.2e-05	0.000365	CcSEcCtD
Cidofovir—TYMP—Metabolism—TYMS—pancreatic cancer	4.2e-05	0.00188	CbGpPWpGaD
Cidofovir—Dermatitis—Fluorouracil—pancreatic cancer	4.2e-05	0.000365	CcSEcCtD
Cidofovir—Pharyngitis—Doxorubicin—pancreatic cancer	4.19e-05	0.000365	CcSEcCtD
Cidofovir—Decreased appetite—Docetaxel—pancreatic cancer	4.18e-05	0.000363	CcSEcCtD
Cidofovir—Headache—Fluorouracil—pancreatic cancer	4.18e-05	0.000363	CcSEcCtD
Cidofovir—Urinary tract disorder—Doxorubicin—pancreatic cancer	4.17e-05	0.000363	CcSEcCtD
Cidofovir—Oedema peripheral—Doxorubicin—pancreatic cancer	4.16e-05	0.000362	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.15e-05	0.000361	CcSEcCtD
Cidofovir—Angiopathy—Epirubicin—pancreatic cancer	4.14e-05	0.00036	CcSEcCtD
Cidofovir—Urethral disorder—Doxorubicin—pancreatic cancer	4.14e-05	0.00036	CcSEcCtD
Cidofovir—Nausea—Irinotecan—pancreatic cancer	4.13e-05	0.000359	CcSEcCtD
Cidofovir—Mediastinal disorder—Epirubicin—pancreatic cancer	4.12e-05	0.000358	CcSEcCtD
Cidofovir—Pain—Docetaxel—pancreatic cancer	4.11e-05	0.000358	CcSEcCtD
Cidofovir—Constipation—Docetaxel—pancreatic cancer	4.11e-05	0.000358	CcSEcCtD
Cidofovir—Chills—Epirubicin—pancreatic cancer	4.1e-05	0.000356	CcSEcCtD
Cidofovir—Visual impairment—Doxorubicin—pancreatic cancer	4.07e-05	0.000354	CcSEcCtD
Cidofovir—Alopecia—Epirubicin—pancreatic cancer	4.04e-05	0.000351	CcSEcCtD
Cidofovir—Nausea—Gemcitabine—pancreatic cancer	4.03e-05	0.00035	CcSEcCtD
Cidofovir—Erythema multiforme—Doxorubicin—pancreatic cancer	4e-05	0.000347	CcSEcCtD
Cidofovir—Feeling abnormal—Docetaxel—pancreatic cancer	3.96e-05	0.000345	CcSEcCtD
Cidofovir—Nausea—Fluorouracil—pancreatic cancer	3.96e-05	0.000344	CcSEcCtD
Cidofovir—Eye disorder—Doxorubicin—pancreatic cancer	3.95e-05	0.000343	CcSEcCtD
Cidofovir—Tinnitus—Doxorubicin—pancreatic cancer	3.94e-05	0.000342	CcSEcCtD
Cidofovir—Gastrointestinal pain—Docetaxel—pancreatic cancer	3.93e-05	0.000342	CcSEcCtD
Cidofovir—Flushing—Doxorubicin—pancreatic cancer	3.92e-05	0.000341	CcSEcCtD
Cidofovir—Flatulence—Epirubicin—pancreatic cancer	3.92e-05	0.000341	CcSEcCtD
Cidofovir—Tension—Epirubicin—pancreatic cancer	3.9e-05	0.000339	CcSEcCtD
Cidofovir—Dysgeusia—Epirubicin—pancreatic cancer	3.89e-05	0.000338	CcSEcCtD
Cidofovir—Nervousness—Epirubicin—pancreatic cancer	3.86e-05	0.000336	CcSEcCtD
Cidofovir—Back pain—Epirubicin—pancreatic cancer	3.85e-05	0.000334	CcSEcCtD
Cidofovir—Angiopathy—Doxorubicin—pancreatic cancer	3.83e-05	0.000333	CcSEcCtD
Cidofovir—Muscle spasms—Epirubicin—pancreatic cancer	3.82e-05	0.000332	CcSEcCtD
Cidofovir—Mediastinal disorder—Doxorubicin—pancreatic cancer	3.81e-05	0.000331	CcSEcCtD
Cidofovir—Abdominal pain—Docetaxel—pancreatic cancer	3.8e-05	0.000331	CcSEcCtD
Cidofovir—Body temperature increased—Docetaxel—pancreatic cancer	3.8e-05	0.000331	CcSEcCtD
Cidofovir—Chills—Doxorubicin—pancreatic cancer	3.79e-05	0.00033	CcSEcCtD
Cidofovir—Alopecia—Doxorubicin—pancreatic cancer	3.73e-05	0.000325	CcSEcCtD
Cidofovir—Ill-defined disorder—Epirubicin—pancreatic cancer	3.69e-05	0.000321	CcSEcCtD
Cidofovir—Anaemia—Epirubicin—pancreatic cancer	3.67e-05	0.000319	CcSEcCtD
Cidofovir—Agitation—Epirubicin—pancreatic cancer	3.65e-05	0.000318	CcSEcCtD
Cidofovir—Flatulence—Doxorubicin—pancreatic cancer	3.62e-05	0.000315	CcSEcCtD
Cidofovir—Tension—Doxorubicin—pancreatic cancer	3.61e-05	0.000314	CcSEcCtD
Cidofovir—Dysgeusia—Doxorubicin—pancreatic cancer	3.6e-05	0.000313	CcSEcCtD
Cidofovir—Malaise—Epirubicin—pancreatic cancer	3.59e-05	0.000312	CcSEcCtD
Cidofovir—Nervousness—Doxorubicin—pancreatic cancer	3.57e-05	0.000311	CcSEcCtD
Cidofovir—Vertigo—Epirubicin—pancreatic cancer	3.57e-05	0.00031	CcSEcCtD
Cidofovir—Syncope—Epirubicin—pancreatic cancer	3.57e-05	0.00031	CcSEcCtD
Cidofovir—Leukopenia—Epirubicin—pancreatic cancer	3.56e-05	0.000309	CcSEcCtD
Cidofovir—Back pain—Doxorubicin—pancreatic cancer	3.56e-05	0.000309	CcSEcCtD
Cidofovir—Hypersensitivity—Docetaxel—pancreatic cancer	3.54e-05	0.000308	CcSEcCtD
Cidofovir—Muscle spasms—Doxorubicin—pancreatic cancer	3.54e-05	0.000307	CcSEcCtD
Cidofovir—Loss of consciousness—Epirubicin—pancreatic cancer	3.49e-05	0.000304	CcSEcCtD
Cidofovir—Cough—Epirubicin—pancreatic cancer	3.47e-05	0.000302	CcSEcCtD
Cidofovir—Asthenia—Docetaxel—pancreatic cancer	3.45e-05	0.0003	CcSEcCtD
Cidofovir—Convulsion—Epirubicin—pancreatic cancer	3.44e-05	0.000299	CcSEcCtD
Cidofovir—Hypertension—Epirubicin—pancreatic cancer	3.43e-05	0.000298	CcSEcCtD
Cidofovir—TYMP—Metabolism—APOE—pancreatic cancer	3.42e-05	0.00153	CbGpPWpGaD
Cidofovir—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.41e-05	0.000297	CcSEcCtD
Cidofovir—Pruritus—Docetaxel—pancreatic cancer	3.4e-05	0.000296	CcSEcCtD
Cidofovir—Anaemia—Doxorubicin—pancreatic cancer	3.4e-05	0.000296	CcSEcCtD
Cidofovir—Arthralgia—Epirubicin—pancreatic cancer	3.38e-05	0.000294	CcSEcCtD
Cidofovir—Chest pain—Epirubicin—pancreatic cancer	3.38e-05	0.000294	CcSEcCtD
Cidofovir—Myalgia—Epirubicin—pancreatic cancer	3.38e-05	0.000294	CcSEcCtD
Cidofovir—Agitation—Doxorubicin—pancreatic cancer	3.38e-05	0.000294	CcSEcCtD
Cidofovir—Anxiety—Epirubicin—pancreatic cancer	3.37e-05	0.000293	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	3.36e-05	0.000292	CcSEcCtD
Cidofovir—Discomfort—Epirubicin—pancreatic cancer	3.34e-05	0.000291	CcSEcCtD
Cidofovir—Malaise—Doxorubicin—pancreatic cancer	3.32e-05	0.000288	CcSEcCtD
Cidofovir—Dry mouth—Epirubicin—pancreatic cancer	3.31e-05	0.000288	CcSEcCtD
Cidofovir—Vertigo—Doxorubicin—pancreatic cancer	3.3e-05	0.000287	CcSEcCtD
Cidofovir—Syncope—Doxorubicin—pancreatic cancer	3.3e-05	0.000287	CcSEcCtD
Cidofovir—Leukopenia—Doxorubicin—pancreatic cancer	3.29e-05	0.000286	CcSEcCtD
Cidofovir—Diarrhoea—Docetaxel—pancreatic cancer	3.29e-05	0.000286	CcSEcCtD
Cidofovir—Confusional state—Epirubicin—pancreatic cancer	3.27e-05	0.000284	CcSEcCtD
Cidofovir—Oedema—Epirubicin—pancreatic cancer	3.24e-05	0.000282	CcSEcCtD
Cidofovir—Anaphylactic shock—Epirubicin—pancreatic cancer	3.24e-05	0.000282	CcSEcCtD
Cidofovir—Loss of consciousness—Doxorubicin—pancreatic cancer	3.23e-05	0.000281	CcSEcCtD
Cidofovir—Infection—Epirubicin—pancreatic cancer	3.22e-05	0.00028	CcSEcCtD
Cidofovir—Cough—Doxorubicin—pancreatic cancer	3.21e-05	0.000279	CcSEcCtD
Cidofovir—Shock—Epirubicin—pancreatic cancer	3.19e-05	0.000277	CcSEcCtD
Cidofovir—Convulsion—Doxorubicin—pancreatic cancer	3.19e-05	0.000277	CcSEcCtD
Cidofovir—Nervous system disorder—Epirubicin—pancreatic cancer	3.18e-05	0.000277	CcSEcCtD
Cidofovir—Dizziness—Docetaxel—pancreatic cancer	3.18e-05	0.000277	CcSEcCtD
Cidofovir—Thrombocytopenia—Epirubicin—pancreatic cancer	3.18e-05	0.000276	CcSEcCtD
Cidofovir—Hypertension—Doxorubicin—pancreatic cancer	3.18e-05	0.000276	CcSEcCtD
Cidofovir—Tachycardia—Epirubicin—pancreatic cancer	3.17e-05	0.000275	CcSEcCtD
Cidofovir—Skin disorder—Epirubicin—pancreatic cancer	3.15e-05	0.000274	CcSEcCtD
Cidofovir—Hyperhidrosis—Epirubicin—pancreatic cancer	3.14e-05	0.000273	CcSEcCtD
Cidofovir—Arthralgia—Doxorubicin—pancreatic cancer	3.13e-05	0.000272	CcSEcCtD
Cidofovir—Chest pain—Doxorubicin—pancreatic cancer	3.13e-05	0.000272	CcSEcCtD
Cidofovir—Myalgia—Doxorubicin—pancreatic cancer	3.13e-05	0.000272	CcSEcCtD
Cidofovir—Anxiety—Doxorubicin—pancreatic cancer	3.12e-05	0.000271	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	3.11e-05	0.00027	CcSEcCtD
Cidofovir—Discomfort—Doxorubicin—pancreatic cancer	3.09e-05	0.000269	CcSEcCtD
Cidofovir—Anorexia—Epirubicin—pancreatic cancer	3.09e-05	0.000269	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CG—pancreatic cancer	3.08e-05	0.00138	CbGpPWpGaD
Cidofovir—Dry mouth—Doxorubicin—pancreatic cancer	3.06e-05	0.000266	CcSEcCtD
Cidofovir—Vomiting—Docetaxel—pancreatic cancer	3.06e-05	0.000266	CcSEcCtD
Cidofovir—Rash—Docetaxel—pancreatic cancer	3.03e-05	0.000264	CcSEcCtD
Cidofovir—Hypotension—Epirubicin—pancreatic cancer	3.03e-05	0.000264	CcSEcCtD
Cidofovir—Dermatitis—Docetaxel—pancreatic cancer	3.03e-05	0.000263	CcSEcCtD
Cidofovir—Confusional state—Doxorubicin—pancreatic cancer	3.03e-05	0.000263	CcSEcCtD
Cidofovir—Headache—Docetaxel—pancreatic cancer	3.01e-05	0.000262	CcSEcCtD
Cidofovir—Anaphylactic shock—Doxorubicin—pancreatic cancer	3e-05	0.000261	CcSEcCtD
Cidofovir—Oedema—Doxorubicin—pancreatic cancer	3e-05	0.000261	CcSEcCtD
Cidofovir—Infection—Doxorubicin—pancreatic cancer	2.98e-05	0.000259	CcSEcCtD
Cidofovir—TYMP—Metabolism—PPARG—pancreatic cancer	2.98e-05	0.00133	CbGpPWpGaD
Cidofovir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.96e-05	0.000257	CcSEcCtD
Cidofovir—Shock—Doxorubicin—pancreatic cancer	2.95e-05	0.000257	CcSEcCtD
Cidofovir—Nervous system disorder—Doxorubicin—pancreatic cancer	2.94e-05	0.000256	CcSEcCtD
Cidofovir—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.94e-05	0.000256	CcSEcCtD
Cidofovir—Insomnia—Epirubicin—pancreatic cancer	2.93e-05	0.000255	CcSEcCtD
Cidofovir—Tachycardia—Doxorubicin—pancreatic cancer	2.93e-05	0.000255	CcSEcCtD
Cidofovir—Skin disorder—Doxorubicin—pancreatic cancer	2.92e-05	0.000253	CcSEcCtD
Cidofovir—Paraesthesia—Epirubicin—pancreatic cancer	2.91e-05	0.000253	CcSEcCtD
Cidofovir—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.9e-05	0.000252	CcSEcCtD
Cidofovir—Dyspnoea—Epirubicin—pancreatic cancer	2.89e-05	0.000251	CcSEcCtD
Cidofovir—Somnolence—Epirubicin—pancreatic cancer	2.88e-05	0.000251	CcSEcCtD
Cidofovir—Anorexia—Doxorubicin—pancreatic cancer	2.86e-05	0.000249	CcSEcCtD
Cidofovir—Nausea—Docetaxel—pancreatic cancer	2.86e-05	0.000248	CcSEcCtD
Cidofovir—Dyspepsia—Epirubicin—pancreatic cancer	2.86e-05	0.000248	CcSEcCtD
Cidofovir—Decreased appetite—Epirubicin—pancreatic cancer	2.82e-05	0.000245	CcSEcCtD
Cidofovir—Hypotension—Doxorubicin—pancreatic cancer	2.81e-05	0.000244	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.8e-05	0.000243	CcSEcCtD
Cidofovir—Constipation—Epirubicin—pancreatic cancer	2.77e-05	0.000241	CcSEcCtD
Cidofovir—Pain—Epirubicin—pancreatic cancer	2.77e-05	0.000241	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.74e-05	0.000238	CcSEcCtD
Cidofovir—Insomnia—Doxorubicin—pancreatic cancer	2.72e-05	0.000236	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CD—pancreatic cancer	2.71e-05	0.00122	CbGpPWpGaD
Cidofovir—Paraesthesia—Doxorubicin—pancreatic cancer	2.7e-05	0.000234	CcSEcCtD
Cidofovir—Dyspnoea—Doxorubicin—pancreatic cancer	2.68e-05	0.000233	CcSEcCtD
Cidofovir—Feeling abnormal—Epirubicin—pancreatic cancer	2.67e-05	0.000232	CcSEcCtD
Cidofovir—Somnolence—Doxorubicin—pancreatic cancer	2.67e-05	0.000232	CcSEcCtD
Cidofovir—Gastrointestinal pain—Epirubicin—pancreatic cancer	2.65e-05	0.000231	CcSEcCtD
Cidofovir—Dyspepsia—Doxorubicin—pancreatic cancer	2.64e-05	0.00023	CcSEcCtD
Cidofovir—Decreased appetite—Doxorubicin—pancreatic cancer	2.61e-05	0.000227	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.59e-05	0.000225	CcSEcCtD
Cidofovir—Urticaria—Epirubicin—pancreatic cancer	2.58e-05	0.000224	CcSEcCtD
Cidofovir—Pain—Doxorubicin—pancreatic cancer	2.57e-05	0.000223	CcSEcCtD
Cidofovir—Constipation—Doxorubicin—pancreatic cancer	2.57e-05	0.000223	CcSEcCtD
Cidofovir—Abdominal pain—Epirubicin—pancreatic cancer	2.56e-05	0.000223	CcSEcCtD
Cidofovir—Body temperature increased—Epirubicin—pancreatic cancer	2.56e-05	0.000223	CcSEcCtD
Cidofovir—Feeling abnormal—Doxorubicin—pancreatic cancer	2.47e-05	0.000215	CcSEcCtD
Cidofovir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.45e-05	0.000213	CcSEcCtD
Cidofovir—Hypersensitivity—Epirubicin—pancreatic cancer	2.39e-05	0.000208	CcSEcCtD
Cidofovir—Urticaria—Doxorubicin—pancreatic cancer	2.38e-05	0.000207	CcSEcCtD
Cidofovir—Abdominal pain—Doxorubicin—pancreatic cancer	2.37e-05	0.000206	CcSEcCtD
Cidofovir—Body temperature increased—Doxorubicin—pancreatic cancer	2.37e-05	0.000206	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CB—pancreatic cancer	2.36e-05	0.00106	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—PTGS2—pancreatic cancer	2.34e-05	0.00105	CbGpPWpGaD
Cidofovir—Asthenia—Epirubicin—pancreatic cancer	2.33e-05	0.000202	CcSEcCtD
Cidofovir—Pruritus—Epirubicin—pancreatic cancer	2.3e-05	0.0002	CcSEcCtD
Cidofovir—Diarrhoea—Epirubicin—pancreatic cancer	2.22e-05	0.000193	CcSEcCtD
Cidofovir—Hypersensitivity—Doxorubicin—pancreatic cancer	2.21e-05	0.000192	CcSEcCtD
Cidofovir—Asthenia—Doxorubicin—pancreatic cancer	2.15e-05	0.000187	CcSEcCtD
Cidofovir—Dizziness—Epirubicin—pancreatic cancer	2.15e-05	0.000187	CcSEcCtD
Cidofovir—Pruritus—Doxorubicin—pancreatic cancer	2.12e-05	0.000185	CcSEcCtD
Cidofovir—Vomiting—Epirubicin—pancreatic cancer	2.06e-05	0.000179	CcSEcCtD
Cidofovir—Diarrhoea—Doxorubicin—pancreatic cancer	2.05e-05	0.000179	CcSEcCtD
Cidofovir—Rash—Epirubicin—pancreatic cancer	2.05e-05	0.000178	CcSEcCtD
Cidofovir—Dermatitis—Epirubicin—pancreatic cancer	2.04e-05	0.000178	CcSEcCtD
Cidofovir—TYMP—Metabolism—PTEN—pancreatic cancer	2.04e-05	0.000915	CbGpPWpGaD
Cidofovir—Headache—Epirubicin—pancreatic cancer	2.03e-05	0.000177	CcSEcCtD
Cidofovir—Dizziness—Doxorubicin—pancreatic cancer	1.99e-05	0.000173	CcSEcCtD
Cidofovir—Nausea—Epirubicin—pancreatic cancer	1.93e-05	0.000168	CcSEcCtD
Cidofovir—Vomiting—Doxorubicin—pancreatic cancer	1.91e-05	0.000166	CcSEcCtD
Cidofovir—Rash—Doxorubicin—pancreatic cancer	1.89e-05	0.000165	CcSEcCtD
Cidofovir—Dermatitis—Doxorubicin—pancreatic cancer	1.89e-05	0.000164	CcSEcCtD
Cidofovir—Headache—Doxorubicin—pancreatic cancer	1.88e-05	0.000163	CcSEcCtD
Cidofovir—Nausea—Doxorubicin—pancreatic cancer	1.78e-05	0.000155	CcSEcCtD
Cidofovir—TYMP—Metabolism—PIK3CA—pancreatic cancer	1.44e-05	0.000646	CbGpPWpGaD
Cidofovir—TYMP—Metabolism—AKT1—pancreatic cancer	1.18e-05	0.000527	CbGpPWpGaD
